Journal of Medical Microbiology and Infectious Diseases
The Journal of Medical Microbiology and Infectious Diseases (JoMMID) is a significant publication in the field of medical microbiology and infectious diseases. Published by the Pasteur Institute of Iran, this open access journal has a broad scope, covering diverse aspects of pathogenic research and clinical practice.
Overview[edit | edit source]
JoMMID offers a platform for a wide range of manuscripts, including original articles, review articles, case studies, and more. It is known for its rigorous double anonymous peer review process and its commitment to scientific and ethical standards.
Access and Publication[edit | edit source]
The journal does not charge any publication fees or APCs, which promotes equitable access for authors worldwide. The average time from submission to publication is approximately 12 weeks. All published articles are available under a CC BY-NC-ND license.
Impact[edit | edit source]
Since its inception in 2013, the JoMMID has contributed significantly to the dissemination of high-quality research in its field. It has facilitated the free sharing of scientific knowledge, adhering to the principles of open access.
Journal of Infectious Diseases and Medical Microbiology[edit | edit source]
Another notable journal in this domain is the Journal of Infectious Diseases and Medical Microbiology. This peer-reviewed publication focuses on the development of medical drugs and diagnostic tools for infectious diseases. It also emphasizes the creation of new antibiotics and microbiological methods.
Scope[edit | edit source]
The journal's scope includes basic and applied research in medical microbiology and immunology, particularly studies that accelerate the process of identifying and combating pathogenic microbes.
Editorial Process[edit | edit source]
Submissions are subject to a single-blind peer review. For authors seeking faster publication, the journal offers a Fast Editorial Execution and Review Process (FEE-Review Process) at an additional cost.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
